Efficacy of combination therapy of DPP-4 inhibitor and alpha glucosidase inhibitor in insurin treaaed type 2 diabetes.

Efficacy of combination therapy of DPP-4 inhibitor and alpha glucosidase inhibitor in insurin treaaed type 2 diabetes. - Efficacy of combination therapy of DPP-4 inhibitor and alpha glucosidase inhibitor in insurin treaaed type 2 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011815

Enrollment

Registered

2013-09-19

Start date

2013-08-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Drug administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 daibetes who have not been treated with DPP-4 inhibitors or alpha glucosidase inhibitors

Exclusion criteria

Exclusion criteria: Patients with severe liver dysfunction and renal dysfunction

Design outcomes

Primary

Measure	Time frame
CGM results and the values of markers for glycemic control	—

Countries

Japan

Contacts

Public ContactMiyako Kishimoto

National Center for Global Health and Medicine Department of Endocrinology, Diabetes, and Metabolism

mkishimo@hosp.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026